Mechanical Heart Valves Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

$2500
Buy Report Download FREE Resources

Published: September 17, 2024 Report Code: GDME1816EPD-ST

Select Item

Mechanical Heart Valves Pipeline Market Report Overview

Mechanical heart valves are generally made of non–physiological materials with a mobile occluder, made of rigid materials. This segment comprises of mechanical sutured mitral valve replacements and mechanical sutured aortic valve replacements.

The mechanical heart valves pipeline market research report comprehensive information about the mechanical heart valves pipeline products with a comparative analysis of the products at various stages of development. The report also includes information about the clinical trials which are in progress.

Key Territories ·       The US

·       India

·       China
Key Regulatory Paths ·       PMA

·       ICAC

·       NMPA
Leading Companies ·       Artivion Inc

·       Autus Valve Technologies Inc

·       Indian Institute of Technology, Kanpur

·       Innovator Lab Consultants India Pvt Ltd

·       Innovia LLC
Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Mechanical Heart Valves Pipeline Market Segmentation by Territories

The key territories in the mechanical heart valves pipeline market are the US, India, and China among others. As of September 2024, the US accounts for the highest number of pipeline products.

Mechanical Heart Valves Pipeline Market Analysis by Territories, 2024 (%)

Mechanical Heart Valves Pipeline Market Analysis by Territories, 2024 (%)

Buy the Full Report for More Territory Insights into the Mechanical Heart Valves Pipeline Market

Download a Free Report Sample

Mechanical Heart Valves Pipeline Market Segmentation by Regulatory Paths

The key regulatory paths in the mechanical heart valves pipeline products market are PMA, ICAC, and NMPA. As of September 2024, PMA is the most followed pathway for pipeline products in the mechanical heart valves market.

Mechanical Heart Valves Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Mechanical Heart Valves Pipeline Market Analysis by Regulatory Paths, 2024 (%)

Buy the Full Report for More Regulatory Path Insights into the Mechanical Heart Valves Pipeline Market

Download a Free Report Sample

Mechanical Heart Valves Pipeline Market – Competitive Landscape

A few of the leading companies associated with the mechanical heart valves pipeline market are:

  • Artivion Inc
  • Autus Valve Technologies Inc
  • Indian Institute of Technology, Kanpur
  • Innovator Lab Consultants India Pvt Ltd
  • Innovia LLC

Artivion Inc: Headquartered in Kennesaw, Georgia, the US, Artivion Inc, formerly CryoLife Inc, is a medical device company. It specializes in the manufacturing, processing, and distribution of medical devices and implantable human tissues. The company’s product portfolio includes aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion’s products are primarily used in cardiac and vascular surgeries, catering to patients with aortic conditions.

Autus Valve Technologies Inc: Autus Valve Technologies Inc (AVT) focuses on development of prosthetic heart valves. AVT is headquartered in Needham, Massachusetts, the US.

Indian Institute of Technology, Kanpur: Indian Institute of Technology Kanpur (IIT Kanpur) instructs students to make them competent engineers and scientists. The institute is based in Kanpur, India.

Mechanical Heart Valves Pipeline Market Analysis by Companies, 2024

Mechanical Heart Valves Pipeline Market Analysis by Companies, 2024

Buy the Full Report for More Company Insights into the Mechanical Heart Valves Pipeline Market

Download a Free Report Sample

Segments Covered in the Report

Mechanical Heart Valves Pipeline Market Territories Outlook (2024)

  • The US
  • India
  • China

Mechanical Heart Valves Pipeline Market Regulatory Paths Outlook (2024)

  • PMA
  • ICAC
  • NMPA

Scope

This report provides:

  • An extensive coverage of the mechanical heart valves under development.

  • A detailed list of major pipeline products which includes product description, licensing and collaboration details, and other developmental activities.

  • Reviews of major players involved in the development of mechanical heart valves and lists of all their pipeline projects.

  • Coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage.

  • Key clinical trial data of ongoing clinical trials specific to pipeline products.

  • Recent developments in the segment/industry.

Reasons to Buy

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies.

  • Identify emerging players with potentially strong product portfolios and create effective counter strategies to gain a competitive advantage.

  • Identify and understand important and diverse types of mechanical heart valves under development.

  • Develop market-entry and market-expansion strategies.

  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline.

  • Carry out an in-depth analysis of the product’s current stage of development, territory, and estimated launch date.

Artivion Inc
Autus Valve Technologies Inc
Indian Institute of Technology, Kanpur
Innovator Lab Consultants India Pvt Ltd
Innovia LLC
Meril Life Sciences Pvt Ltd
Shanghai Aoliu Medical Technology Co Ltd
TTK Healthcare Ltd
University of Pittsburgh Medical Center

Table of Contents

  • 1. Table of Contents

    • 1.1. List of Tables

    • 1.2. List of Figures

  • 2. Introduction

    • 2.1. Mechanical Heart Valves Overview

  • 3. Products under Development

    • 3.1. Mechanical Heart Valves – Pipeline Products by Stage of Development

    • 3.2. Mechanical Heart Valves – Pipeline Products by Segment

    • 3.3. Mechanical Heart Valves – Pipeline Products by Territory

    • 3.4. Mechanical Heart Valves – Pipeline Products by Regulatory Path

    • 3.5. Mechanical Heart Valves – Pipeline Products by Estimated Approval Date

    • 3.6. Mechanical Heart Valves – Ongoing Clinical Trials

  • 4. Mechanical Heart Valves – Pipeline Products under Development by Companies

    • 4.1. Mechanical Heart Valves Companies – Pipeline Products by Stage of Development

    • 4.2. Mechanical Heart Valves – Pipeline Products by Stage of Development

  • 5. Mechanical Heart Valves Companies and Product Overview

    • 5.1. Artivion Inc Company Overview

      • 5.1.1. Artivion Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.2. Autus Valve Technologies Inc Company Overview

      • 5.2.1. Autus Valve Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview

    • 5.3. Indian Institute of Technology, Kanpur Company Overview

      • 5.3.1. Indian Institute of Technology, Kanpur Pipeline Products & Ongoing Clinical Trials Overview

    • 5.4. Innovator Lab Consultants India Pvt Ltd Company Overview

      • 5.4.1. Innovator Lab Consultants India Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.5. Innovia LLC Company Overview

      • 5.5.1. Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview

    • 5.6. Meril Life Sciences Pvt Ltd Company Overview

      • 5.6.1. Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.7. Shanghai Aoliu Medical Technology Co Ltd Company Overview

      • 5.7.1. Shanghai Aoliu Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.8. TTK Healthcare Ltd Company Overview

      • 5.8.1. TTK Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview

    • 5.9. University of Pittsburgh Medical Center Company Overview

      • 5.9.1. University of Pittsburgh Medical Center Pipeline Products & Ongoing Clinical Trials Overview

  • 6. Mechanical Heart Valves- Recent Developments

    • 6.1. Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

    • 6.2. Aug 27, 2024: Medtronic Chairman and CEO Geoff Martha to Speak at the Wells Fargo Healthcare Conference

    • 6.3. Jun 13, 2024: Medtronic Confirms Global Layoffs

    • 6.4. Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference

  • 7. Appendix

    • 7.1. Methodology

    • 7.2. About GlobalData

    • 7.3. Contact Us

    • 7.4. Disclaimer

Table

Mechanical Heart Valves – Pipeline Products by Stage of Development 7

Mechanical Heart Valves – Pipeline Products by Segment 8

Mechanical Heart Valves – Pipeline Products by Territory 9

Mechanical Heart Valves – Pipeline Products by Regulatory Path 10

Mechanical Heart Valves – Pipeline Products by Estimated Approval Date 11

Mechanical Heart Valves – Ongoing Clinical Trials 12

Mechanical Heart Valves Companies – Pipeline Products by Stage of Development 13

Mechanical Heart Valves – Pipeline Products by Stage of Development 14

Artivion Inc Pipeline Products & Ongoing Clinical Trials Overview 15

On-X Mechanical Aortic Valve – ELIQUIS – Product Status 15

On-X Mechanical Aortic Valve – ELIQUIS – Product Description 15

On-X Mitral Valve-Low INR – Product Status 16

On-X Mitral Valve-Low INR – Product Description 16

Autus Valve Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 17

Autus Size-Adaptable Valve – Product Status 17

Autus Size-Adaptable Valve – Product Description 17

Autus Valve Technologies Inc – Ongoing Clinical Trials Overview 18

Autus Size-Adaptable Valve – Autus Size-Adjustable Valve for Surgical Pulmonary Valve Replacement Pivotal Study 19

Indian Institute of Technology, Kanpur Pipeline Products & Ongoing Clinical Trials Overview 20

Mechanical Heart Valve – Closed – Product Status 20

Mechanical Heart Valve – Closed – Product Description 20

Mechanical Heart Valve – Open – Product Status 21

Mechanical Heart Valve – Open – Product Description 21

Innovator Lab Consultants India Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 22

Mechanical Heart Valve 2.0 – Product Status 22

Mechanical Heart Valve 2.0 – Product Description 22

Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview 23

Minimally Invasive Synthetic Tri – Leaflet Heart Valve – Product Status 23

Minimally Invasive Synthetic Tri – Leaflet Heart Valve – Product Description 23

Percutaneous Synthetic Tri – Leaflet Heart Valve – Product Status 24

Percutaneous Synthetic Tri – Leaflet Heart Valve – Product Description 24

Sutured In Synthetic Tri – Leaflet Heart Valve – Product Status 24

Sutured In Synthetic Tri – Leaflet Heart Valve – Product Description 24

Meril Life Sciences Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 25

Miltonia-UNO – Product Status 25

Miltonia-UNO – Product Description 25

MyVal 2 – Product Status 26

MyVal 2 – Product Description 26

MyVal Hexa – Product Status 26

MyVal Hexa – Product Description 26

Myval Rondevu – Product Status 27

Myval Rondevu – Product Description 27

Shanghai Aoliu Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 28

Congenital Heart Valve Device – Product Status 28

Congenital Heart Valve Device – Product Description 28

TTK Healthcare Ltd Pipeline Products & Ongoing Clinical Trials Overview 29

Second Generation TTK-Chitra Heart valve – Product Status 29

Second Generation TTK-Chitra Heart valve – Product Description 29

University of Pittsburgh Medical Center Pipeline Products & Ongoing Clinical Trials Overview 30

Infant Metallic Valve – Product Status 30

Infant Metallic Valve – Product Description 30

Glossary 34

Figures

Mechanical Heart Valves – Pipeline Products by Stage of Development 7

Mechanical Heart Valves – Pipeline Products by Segment 8

Mechanical Heart Valves – Pipeline Products by Territory 9

Mechanical Heart Valves – Pipeline Products by Regulatory Path 10

Mechanical Heart Valves – Pipeline Products by Estimated Approval Date 11

Mechanical Heart Valves – Ongoing Clinical Trials 12

Frequently asked questions

Mechanical Heart Valves Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies standard reports
Currency USD
$2,500

Can be used by individual purchaser only

Most Popular
$5,000

Can be shared by unlimited users within one corporate location e.g. a regional office

$7,500

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Add to Basket

Undecided about purchasing this report?

Enquire Before Buying Download FREE Resources

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Sample Report

Mechanical Heart Valves Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image
testimonial-image

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

 Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

 Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

 Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

 Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

 Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

 Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

 Senior Account Manager, TSYS

Related reports

View more Cardiovascular Devices reports
Medical Devices
New
Global M&A Deals in H1 2026 - Top Themes by…
$495 | August 2026
Medical Devices
New
Medical Devices M&A Deals H1 2026 - Top Themes: Strategic…
$495 | July 2026
Medical Devices
New
AI-designed Materials: Market Trends and Innovations
$995 | July 2026
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Mechanical Heart Valves Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies in real time.

  • Access a live Mechanical Heart Valves Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.
Tell me more